PrEP Project Steering Group

E-mail Print

The steering committee provides guidance, leadership, and expertise to the working groups established by the Forum. It has twenty-three members from across the sectors and regions, including agency, civil society, academia, and industry. The primary goal of the steering committee is to discuss credible and convincing ways to demonstrate that a new intervention prevents transmission of HIV in a region where it would be transmitted in the absence of the use of pre-exposure prophylaxis (PrEP). (* Denotes Steering Committee co-chairs.)

Categories Members Affiliations 
     
Academic Kenneth Mayer* The Fenway Institute. Harvard Medical School
  Helen Rees* Wits Reproductive Health and HIV Institute
  Connie Celum University of Washington
  Sinead Delany-Moretlwe University of the Witwatersrand
  Deborah Donnell Fred Hutchinson Cancer Research Center/ HPTN
  Dave Glidden University of California, San Francisco
  Sheena McCormack MRC Clinical Trials Unit at UCL
  Jeremy Sugarman Johns Hopkins Berman Institute of Bioethics
     
Patient Representatives & Advocacy Daniel Driffin HIV Vaccine Trials Network
  Grace Kumwenda Pakachere IHDC
  Mitchell Warren AVAC
  Ntando Yola Desmond Tutu Health Foundation
  Beatriz Grinsztejn Oswaldo Cruz Foundation
  Lut Van Damme Bill & Melinda Gates Foundation
     
Forum Veronica Miller* Forum for Collaborative Research
  Nick Murdock Forum for Collaborative Research
     
Government Benny Kottiri USAID
  Sheryl Zwerski Division of AIDS, Prevention Sciences Program (PSP), NIAID/NNIH
     
Industry Jared Baeten Gilead Sciences, Inc.
  Rafael Campo Merck
  Jim Rooney Gilead Sciences, Inc.
  Vani Vannappagari ViiV Healthcare
     
Regulatory Rachel Baggaley World Health Organization
  Stephanie Buccholz Federal Insititute of Drugs and Medical Devices, Europe
  Regine Lehnert Federal Institute for Drugs and Medical Devices
  Jean-Michel Molina French National Agency for AIDS Research
  Charu Mullick U.S. Food and Drug Administration
  Kimberly Struble U.S. Food and Drug Administration
     
Societies & Organizations Neil Parkin Data First Consulting, Inc.
  Jeffrey Murray Consultant